Literature DB >> 10025793

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

M Filippi1, G Iannucci, C Tortorella, L Minicucci, M A Horsfield, B Colombo, M P Sormani, G Comi.   

Abstract

OBJECTIVE: To identify differences in pathology between the principal clinical phenotypes of MS using conventional and magnetization transfer (MT) MRI.
METHODS: T1-weighted and T2-weighted images as well as MT scans were obtained from 20 controls, 21 patients presenting with clinically isolated syndromes suggestive of MS, and 93 MS patients with relapsing-remitting, secondary progressive, benign, or primary progressive course. Metrics considered: hypointense T1 and T2 lesion volumes, average lesion MT ratio, average brain MT ratio, peak height and position from MT histograms.
RESULTS: MS patients had lower MT metrics than controls. Patients with clinically isolated syndromes had MT measures similar to controls, whereas primary progressive MS patients had lower histogram peak height with normal peak position. Relapsing-remitting MS patients had lower MT measures, higher T2 lesion load and ratio of hypointense T1 to T2 lesion volumes than patients with clinically isolated syndromes, and lower MT ratio and peak height than benign MS patients. Benign MS patients were similar to controls and patients with clinically isolated syndromes. Secondary progressive MS patients had the lowest MT measures and highest lesion loads.
CONCLUSIONS: Pathology in patients with clinically isolated syndromes is confined to modest tissue damage in the lesions seen on T2-weighted scans. Severe damage is important for the later development of disability. However, microscopic damage in normal-appearing white matter may be a major contributor to disability in primary progressive MS.

Entities:  

Mesh:

Year:  1999        PMID: 10025793     DOI: 10.1212/wnl.52.3.588

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  45 in total

1.  Scan-rescan variation of measures derived from brain magnetization transfer ratio histograms obtained in healthy volunteers by use of a semi-interleaved magnetization transfer sequence.

Authors:  M Inglese; M A Horsfield; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

2.  Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy.

Authors:  M Inglese; M Rovaris; S Bianchi; L La Mantia; G L Mancardi; A Ghezzi; P Montagna; F Salvi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

3.  Reproducibility of magnetization transfer ratio histogram-derived measures of the brain in healthy volunteers.

Authors:  M P Sormani; G Iannucci; M A Rocca; G Mastronardo; M Cercignani; L Minicucci; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

Review 4.  Clinical trials and clinical practice in multiple sclerosis: conventional and emerging magnetic resonance imaging technologies.

Authors:  Massimo Filippi; Maria A Rocca; Marco Rovaris
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

5.  Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis.

Authors:  M Cercignani; M Inglese; E Pagani; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

6.  A new method for analyzing histograms of brain magnetization transfer ratios: comparison with existing techniques.

Authors:  Liang Qiang Zhou; Yue Min Zhu; Jérôme Grimaud; Marc Hermier; Marco Rovaris; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

Review 7.  Assessing treatment effects on axonal loss--evidence from MRI monitored clinical trials.

Authors:  Frederik Barkhof
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 8.  Benign multiple sclerosis: does it exist?

Authors:  Jorge Correale; María C Ysrraelit; Marcela P Fiol
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 9.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

Review 10.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.